We further monitored the phosphorylation protein of the PI3K-AKT-mTOR signaling pathway in the two ICC cell lines between the combination-treated groups and DMSO-treated groups (Fig. 7B). This evidence concerns the gene MTOR and intrahepatic cholangiocarcinoma.